Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

Stat News

STAT+: Biotech execs, academic expert lament impact of FDA turnover on rare disease drug development

STAT+: Biotech execs, academic expert lament impact of FDA turnover on rare disease drug development
ShareXFacebook

How the ouster of key officials at the FDA has created anxiety and uncertainty for the developers of rare disease drugs.

S

Source

Stat News

Read full article at Stat News

Opens original article in a new tab

Advertisement

Related Health Stories

Migraine With Aura Tied to Higher Stroke Risk
MedPage Today

Migraine With Aura Tied to Higher Stroke Risk

(MedPage Today) -- Middle-aged and older adults who had migraine with aura had a greater risk of subsequent stroke, a study of 11,000 people showed. Over 6 years, migraine with aura was associated with a 73% higher risk of ischemic stroke compared...

Read more →
Advertisement